Nancy Tengler, Laffer Tengler Investment CIO and David Bahnsen, Managing Partner of the Bahnsen Group, are analyzing the impact of Russian tensions on the market.
U.S. stocks Set to open lower with what may be another volatile session for investors following Large swing I experienced it on Monday.
Nasdaq Composite futures are down 2%, while S & P 500 and Dow futures are down about 0.7%.
| Ticker | safety | last | Change | change % |
|---|---|---|---|---|
| I: DJI | Dow Jones Industrial Average | 34364.5 | +99.13 | + 0.29% |
| SP500 | S & P 500 | 4410.13 | + 12.19 | + 0.28% |
| I: COMP | Nasdaq Composite Index | 13855.129489 | +86.21 | + 0.63% |
Monday’s fierce turnaround, which rebounded from the Dow’s fall of more than 1,000 points, also ended with the worst weekly stretch since the start of the pandemic, following a three-week fall on the S & P 500. Tensions are rising between Russia and the West over concerns that Moscow is planning an invasion of Ukraine, and NATO outlines potential military and ship deployments.
On Tuesday, investors will seek to focus on the earnings of a few high-end stocks, including a quarter that exceeds IBM’s expectations. The stock is set to open with a profit of about 2%.
| Ticker | safety | last | Change | change % |
|---|---|---|---|---|
| IBM | International Business Machines Corporation. | 128.82 | -0.53 | -0.41% |
Johnson & Johnson exceeded Wall Street’s expectations, supported by growth in pharmaceutical sales, but was short on revenue. Johnson & Johnson, based in New Brunswick, NJ, generated $ 4.73 billion in revenue in the fourth quarter, with revenue up 10% to $ 24.8 billion, an estimated $ 25.2 billion. It fell below.The world’s largest healthcare product maker also released strong forecasts for 2022
| Ticker | safety | last | Change | change % |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 162.97 | -1.90 | -1.15% |
In other pharmaceutical news, the Food and Drug Administration has restricted the use of Regeneron and Eli Lilly’s COVID-19 treatment due to lack of efficacy, while Pfizer and BioNTech specifically target Omicron variants. Announced clinical trials of the drug.
| Ticker | safety | last | Change | change % |
|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICAL SINC. | 621.48 | +0.08 | + 0.01% |
| LLY | Eli Lilly and Company | 240.42 | -2.64 | -1.09% |
| PFE | Pfizer Japan Inc | 51.54 | -1.25 | -2.37% |
| BNTX | BioNTech SE | 150.98 | +3.48 | + 2.36% |
Verizon, American Express and 3M also reported prior to Tuesday’s opening bell.
| Ticker | safety | last | Change | change % |
|---|---|---|---|---|
| VZ | VERIZON COMMUNICATION SINC. | 52.96 | -0.20 | -0.38% |
| AXP | AMERICAN EXPRESS CO. | 158.93 | +0.19 | + 0.12% |
| Hmm | 3MCO. | 172.80 | +0.15 | + 0.09% |
Biden plans to lower prices as inflation continues to skyrocket
The Federal Reserve will also begin a two-day meeting with up-to-date information on interest rate decisions set on Wednesday and what continues to be sustained inflation.
“There is a short-term panic, some of which is a high level of uncertainty about what the Fed is trying to do,” said Sylvia Jablonski, chief investment officer of the Defiance ETF. Stated.
Ford closes orders for new $ 20,000 MAVERICK pickups
In cryptocurrencies, Bitcoin continued to recover from Monday’s lows.
Click here to get your FOX business on the go
In energy trading, benchmark US crude added 58 cents to $ 83.89 a barrel in electronic trading on the New York Mercantile Exchange. Brent crude, the international standard, rose 76 cents to $ 87.03 a barrel.
The Associated Press contributed to this report.
